Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wilate in pediatric severe hemophilia A
NCT03376516Phase 3Completed
- Sponsor
- Octapharma
- Start
- Nov 2017
- Primary completion
- Nov 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 3 trial of von Willebrand factor concentrate in hemophilia A, sponsored by Octapharma. Started Nov 2017; status: completed.
02
Drugs
von Willebrand factor concentrate
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT03376516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03376516.